Search research articles
Contact Us
Filters
Showing results (351-360 of 362) with videos related to
Page
of 37
Sort By:
Nature Medicine
|
December 1, 2011
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease
Motoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Blood
|
October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVL
Kate A Markey, Angela C Burman, Tatjana Banovic, et al.
NPJ Digital Medicine
|
September 29, 2024
Blending space and time to talk about cancer in extended reality
Tamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
The Journal of Clinical Investigation
|
April 10, 2018
Recipient mucosal-associated invariant T cells control GVHD within the colon
Antiopi Varelias, Mark D Bunting, Kate L Ormerod, et al.
Blood
|
March 15, 2012
Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets
Kate A Markey, Motoko Koyama, Rachel D Kuns, et al.
Blood Advances
|
January 4, 2018
Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT
Kate H Gartlan, Antiopi Varelias, Motoko Koyama, et al.
Blood
|
August 26, 2021
IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease
Andrea S Henden, Motoko Koyama, Renee J Robb, et al.
Science Translational Medicine
|
August 16, 2013
Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate
Sarah J Nelson, John Kurhanewicz, Daniel B Vigneron, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
January 28, 2014
Mitigation and education
Vinay K Aggarwal, Eric H Tischler, Charles Lautenbach, et al.
The Journal of Arthroplasty
|
December 24, 2013
Mitigation and education
Vinay K Aggarwal, Eric H Tischler, Charles Lautenbach, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 362) with videos related to
Sort By:
Page
of 37
Nature Medicine
|
December 1, 2011
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease
Motoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Blood
|
October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVL
Kate A Markey, Angela C Burman, Tatjana Banovic, et al.
NPJ Digital Medicine
|
September 29, 2024
Blending space and time to talk about cancer in extended reality
Tamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
The Journal of Clinical Investigation
|
April 10, 2018
Recipient mucosal-associated invariant T cells control GVHD within the colon
Antiopi Varelias, Mark D Bunting, Kate L Ormerod, et al.
Blood
|
March 15, 2012
Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets
Kate A Markey, Motoko Koyama, Rachel D Kuns, et al.
Blood Advances
|
January 4, 2018
Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT
Kate H Gartlan, Antiopi Varelias, Motoko Koyama, et al.
Blood
|
August 26, 2021
IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease
Andrea S Henden, Motoko Koyama, Renee J Robb, et al.
Science Translational Medicine
|
August 16, 2013
Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate
Sarah J Nelson, John Kurhanewicz, Daniel B Vigneron, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
January 28, 2014
Mitigation and education
Vinay K Aggarwal, Eric H Tischler, Charles Lautenbach, et al.
The Journal of Arthroplasty
|
December 24, 2013
Mitigation and education
Vinay K Aggarwal, Eric H Tischler, Charles Lautenbach, et al.
Page
of 37